The active constituents found in ginseng have demonstrated a capacity to enhance the gut microbiome’s condition, mitigate inflammation, and positively impact cerebral functions. This conclusion was reached by specialists at Jilin Agricultural University, with the findings detailed in the journal Nutrients.
The researchers concentrated their efforts on examining ginsenosides, polysaccharides, and other bioactive compounds present in ginseng. Their analysis confirmed that these substances possess the ability to alter the composition of the intestinal flora, thereby fortifying the gut’s barrier function and reducing inflammatory responses.
Of particular interest to the scientists was ginseng’s influence on the “gut-brain axis.” It is well-established that gut bacteria play a role in the synthesis of neurotransmitters, regulate immune responses, and affect cognitive abilities, mood, and susceptibility to neurological disorders.
The experts concluded that the active components in ginseng interact with multiple elements within this system. In animal studies, these components were shown to reduce damage to the intestinal lining, promote the proliferation of beneficial microorganisms, and suppress inflammatory processes linked to inflammatory bowel conditions.
Beneficial effects were observed across models of Alzheimer’s disease, Parkinson’s disease, depression, obesity, and diabetes. In many instances, improvements in gut health were accompanied by corresponding changes in brain function and metabolism.
The study’s authors posit that inflammatory processes within the gut exert influence on the central nervous system through immune signaling, hormonal pathways, and the metabolic byproducts of the microbiota.
The researchers emphasize the need for large-scale clinical trials to determine optimal dosages and ascertain the long-term safety of this therapeutic approach.
About the Author
